IBI356
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for IBI356, covering 2025-09-02 to 2026-03-11. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate Efficacy and Safety of IBI356 in Participants With Moderate to Severe Atopic Dermatitis [Phase 2]